Blog

This post is part of our ongoing Healthcare Transactions Series, where we explore legal, operational, and strategic issues that matter most to providers, investors, and entrepreneurs navigating the healthcare business. Today, we’re tackling a nuanced feature in healthcare M&A - earnouts.

Earnouts—provisions that tie part of the purchase price to post-closing performance—are often used to bridge valuation gaps in deals. While common in general M&A, these arrangements pose unique regulatory risks in healthcare, particularly under the federal Stark Law and Anti-Kickback Statute (AKS).

In transactions where sel

This post is part of Mooradian Law’s ongoing Healthcare Transactions Series, where we explore legal, operational, and strategic issues that matter most to providers, investors, and entrepreneurs navigating the healthcare business.

In this week’s installment, we examine why ensuring a smooth transition for clinical and administrative staff in healthcare M&A is essential to preserving business value and achieving a successful integration. Thoughtful handling of workforce issues helps protect your business from financial, legal, and regulatory risks.

At the outset of the transaction, buyers should assess the target organization’s culture to ensure

This post is part of our ongoing Healthcare Transactions Series, where we explore legal, operational, and strategic issues that matter most to providers, investors, and entrepreneurs navigating the business of healthcare. In this installment, we focus on two foundational—but often misunderstood—regulatory concepts: Fair Market Value (FMV) and Commercial Reasonableness (CR). Whether you’re acquiring a practice, structuring a management agreement, or evaluating physician compensation models, understanding FMV and CR is essential to ensuring your deal is not just financially sound—but also legally defensible.

Fair Market Value